Clinical Trial Update: Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes the investigation of recombinant human thrombopoietin for mobilizing peripheral blood progenitor cells in autologous transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Mobilization
• Hematopoietic Stem Cell Transplantation

Drugs mentioned

• recombinant human thrombopoietin (recombinant human thrombopoietin)

Snippet

Sponsor: Hongnan Mo | Conditions: Thrombocytopoietin, Hematopoietic Stem Cell Mobilization | Phase 1, Phase 2 | Status: UNKNOWN